Harnessing iPSC-Derived iTenocytes for Effective Cell-Based Therapy

March 01, 2024
, ,

Summary

This article describes a procedure to produce iTenocytes by generating iPSC-derived mesenchymal stromal cells with combined overexpression of Scleraxis using a lentiviral vector and uniaxial stretching via a 2D bioreactor.